Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Plasma Protein Therapeutics Market to reach USD 47.16 billion by the end of 2029

Global Plasma Protein Therapeutics Market Size study & Forecast, by Product Type (C1 esterase Inhibitors, Albumins, Immunoglobulins, Others), by Application (Hereditary Angioedema, Hemophilia, Primary Immunodeficiency Disorder, Others) and Regional Analysis, 2022-2029

Product Code: HLSDT-24127705
Publish Date: 10-04-2023
Page: 200

Global Plasma Protein Therapeutics Market is valued at approximately USD 27.45 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7% over the forecast period 2022-2029. Plasma protein therapeutics is a biological medicine made up of plasma. It is a biological substance with a distinct chemical composition depending upon how it was produced and processed. The majority of blood is made up of plasma, contains water, salts, proteins, antibodies, and enzymes. The Plasma Protein Therapeutics market is expanding because of factors such as increasing incidence of immune deficiency disorder and surge in geriatric populations. Its prevalence has progressively increased during the last few years.

Plasma protein therapies are used in the treatment of various chronic, life-threatening, and genetic diseases. Its prevalence has progressively increased during the last few years. According to Statista, plasma demand around the world was expected to increase up to 50 million liters by 2020. Furthermore, in 2020, more than 1018.8 metric tons of albumin were consumed worldwide and projected to reach around 1125.5 metric tons by 2022. It is a global protein generated from blood plasma used for cancer diagnostics and therapies, and Morbus Wilson treatments. It is used mostly for cancer diagnostics and therapies. Another important component driving space is increasing geriatric populations. In 2022, Monaco was the country with the highest percentage of total population that was over the age of 65. Monaco has the oldest population in the world with 36 percent of Japanese over 65. Germany on the other hand has 22 percent of its population being over 65 in 2022. In addition Approximately 25% of the world’s population is under 15, while 10% is over 65. The youngest population in the world is found in Africa. Indicating the low life expectancy in many nations, 40% of people on the continent are under the age of 15 and less than 4% are over 65. Contrarily, in Europe, a greater proportion of the population is over 65 than is under 15 years old. Furthermore, in 2021 Baxter International Inc. announced the global launch of PrisMax 2. It is designed to simplify delivery of continuous renal replacement therapy and organ support plasma therapies, while providing flexibility to meet the demands of the intensive care unit . The PrisMax 2 system features the company’s TrueVue digital health portfolio, as well as the PrismaLung blood-gas exchanger that delivers extracorporeal carbon dioxide removal therapy to support acute respiratory dysfunction. However, the high cost of Plasma Protein Therapeutics stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Plasma Protein Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the dominance of increase in healthcare expenditure. According to Statista, the Health Care segment of north America is projected to reach USD 20.77 billion in 2023 and expected to show an annual growth rate of 12.25% in between 2023 to 2027, resulting in a projected market volume of USD 32.97 billion by 2027.Furthermore, Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and increasing research and development related to plasma protein therapies in the market space.

Major market players included in this report are:

Baxter International
CSL Behring
China Biologics
Octapharma USA, Inc
Shire Plc
Takeda Pharmaceutical Company Ltd
ADMA Biologics, Inc

Recent Developments in the Market:
 In April 2020, Kedrion Biopharma collaborated with Kamada Ltd. For manufacturing, development, and distribution of a human plasma-derived Anti-SARS-CoV-2 (COVID-19) polyclonal immunoglobulin (IgG) product as a potential treatment for COVID-19 patients

Global Plasma Protein Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
C1 esterase Inhibitors

By Application:
Hereditary Angioedema
Primary Immunodeficiency Disorder

By Region:
North America
Asia Pacific
South Korea
Latin America
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Plasma Protein Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Plasma Protein Therapeutics Market, by Product Type, 2019-2029 (USD Billion)
1.2.3. Plasma Protein Therapeutics Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Plasma Protein Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Plasma Protein Therapeutics Market Dynamics
3.1. Plasma Protein Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers Increasing incidence of immune deficiency disorders Surge in geriatric populations
3.1.2. Market Challenges High Cost of Plasma Protein Therapeutics
3.1.3. Market Opportunities Rising investments in research and development programs by the pharmaceutical companies

Chapter 4. Global Plasma Protein Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Plasma Protein Therapeutics Market, by Product Type
6.1. Market Snapshot
6.2. Global Plasma Protein Therapeutics Market by Product Type, Performance – Potential Analysis
6.3. Global Plasma Protein Therapeutics Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
6.4. Plasma Protein Therapeutics Market, Sub Segment Analysis
6.4.1. C1 esterase Inhibitors
6.4.2. Albumins
6.4.3. Immunoglobulins
6.4.4. Others
Chapter 7. Global Plasma Protein Therapeutics Market, by Application
7.1. Market Snapshot
7.2. Global Plasma Protein Therapeutics Market by Application, Performance – Potential Analysis
7.3. Global Plasma Protein Therapeutics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Plasma Protein Therapeutics Market, Sub Segment Analysis
7.4.1. Hereditary Angioedema
7.4.2. Haemophilia
7.4.3. Primary Immunodeficiency Disorder
7.4.4. Others
Chapter 8. Global Plasma Protein Therapeutics Market, Regional Analysis
8.1. Plasma Protein Therapeutics Market, Regional Market Snapshot
8.2. North America Plasma Protein Therapeutics Market
8.2.1. U.S. Plasma Protein Therapeutics Market Product Type breakdown estimates & forecasts, 2019-2029 Application breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Plasma Protein Therapeutics Market
8.3. Europe Plasma Protein Therapeutics Market Snapshot
8.3.1. U.K. Plasma Protein Therapeutics Market
8.3.2. Germany Plasma Protein Therapeutics Market
8.3.3. France Plasma Protein Therapeutics Market
8.3.4. Spain Plasma Protein Therapeutics Market
8.3.5. Italy Plasma Protein Therapeutics Market
8.3.6. Rest of Europe Plasma Protein Therapeutics Market
8.4. Asia-Pacific Plasma Protein Therapeutics Market Snapshot
8.4.1. China Plasma Protein Therapeutics Market
8.4.2. India Plasma Protein Therapeutics Market
8.4.3. Japan Plasma Protein Therapeutics Market
8.4.4. Australia Plasma Protein Therapeutics Market
8.4.5. South Korea Plasma Protein Therapeutics Market
8.4.6. Rest of Asia Pacific Plasma Protein Therapeutics Market
8.5. Latin America Plasma Protein Therapeutics Market Snapshot
8.5.1. Brazil Plasma Protein Therapeutics Market
8.5.2. Mexico Plasma Protein Therapeutics Market
8.5.3. Rest of Latin America Plasma Protein Therapeutics Market
8.6. Rest of The World Plasma Protein Therapeutics Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Baxter International Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
9.2.2. Biotest
9.2.3. CSL Behring
9.2.4. China Biologics
9.2.5. GRIFOLS, S.A.
9.2.6. Kedrion
9.2.7. Octapharma USA, Inc
9.2.8. Shire Plc
9.2.9. Takeda Pharmaceutical Company Ltd
9.2.10. ADMA Biologics, Inc

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now